摘要:Correction to:
Scientific Reports 10.1038/s41598-021-87706-w, published online 22 April 2021
The Competing Interests statement in the original version of this Article was incorrect.
“The authors declare no competing interests.”
now reads:
“JPdRV, WDD and RWK are co-founders and managing members of InflamaCORE, LLC and have licensed patents on inflammasome proteins as biomarkers of injury and disease as well as on targeting inflammasome proteins for therapeutic purposes. JPdRV, WDD and RWK are Scientific Advisory Board Members of ZyVersa Therapeutics.”
The original Article has been corrected.